Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeMD, Inc.LFMD · Entity 6521 | Chief Legal Officer & GC | August 22, 2025 | August 26, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeMD, Inc.
Report date August 22, 2025 · Filed August 26, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 388,900 |
Reported balance
After 2025-08-22 transaction · row 1
1 source rowRow 1 · 2025-08-22 · Grant · Acquired 50,000 · Balance 388,900 F1: Represents grant of performance stock which vested on August 22, 2025 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of performance stock which vested on August 22, 2025
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 22, 2025 Filed Aug 26, 2025 22:26 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000922 · form4.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · Chief Legal Officer & GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,900 F1 · price: Represents grant of performance stock which vested on August 22, 2025 Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 22:12 UTC | LifeMD, Inc. LFMD · Entity 6521 | SaleCommon Stock | 15,000 | $12.25 | $183,750.00 |
DisclosureSEC source: 0000912282-25-000686 · form4.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · Chief Legal Officer & GC 10b5-1 filing: No plan indicated Ownership: Indirect · by Spouse Disclosed balance after: 16,100 Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:39 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000358 · form4.xml · nonDerivative · entry 2 Yecies Eric Harold · CIK 0001834563 · Chief Legal Officer & GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 370,000 F2 · price: The restricted shares vested in full on March 31, 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:39 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000358 · form4.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · Chief Legal Officer & GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,000 F1 · price: Represents grant of performance stock which vested on March 31, 2025. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 21:45 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000279 · form4.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · Chief Legal Officer & GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,250 F1 · price: Represents grant of performance stock which vested on March 7, 2025. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 17:37 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 56,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001362118-24-000012 · primary_doc.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · General Counsel & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,250 F1 · price: Performance shares vested on March 21, 2024. F2 · balance_after: The total shares beneficially owned reflect a correction to previously reported ownership. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 22:16 UTC | LifeMD, Inc. LFMD · Entity 6521 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 200,000 | Not disclosed Strike: $7.55 | Not disclosed |
DisclosureSEC source: 0001362118-23-000044 · primary_doc.xml · derivative · entry 2 Yecies Eric Harold · CIK 0001834563 · General Counsel & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires not disclosed F1 · price: The options are being cancelled in exchange for 150,000 restricted shares with 12,500 vesting on June 15, 2023, 37,500 shares on November 20, 2023 and 100,000 shares on January 1, 2024 and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following November 20, 2020. F1 · derivative.exercise_date: The options are being cancelled in exchange for 150,000 restricted shares with 12,500 vesting on June 15, 2023, 37,500 shares on November 20, 2023 and 100,000 shares on January 1, 2024 and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following November 20, 2020. F1 · derivative.expiration_date: The options are being cancelled in exchange for 150,000 restricted shares with 12,500 vesting on June 15, 2023, 37,500 shares on November 20, 2023 and 100,000 shares on January 1, 2024 and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following November 20, 2020. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 22:16 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 150,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001362118-23-000044 · primary_doc.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · General Counsel & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,500 F1 · price: The options are being cancelled in exchange for 150,000 restricted shares with 12,500 vesting on June 15, 2023, 37,500 shares on November 20, 2023 and 100,000 shares on January 1, 2024 and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following November 20, 2020. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 12:33 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 11,500 | $2.60 | $29,900.00 |
DisclosureSEC source: 0001362118-23-000037 · primary_doc.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · General Counsel & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 13:32 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 5,000 | $3.14 | $15,700.00 |
DisclosureSEC source: 0001362118-22-000022 · primary_doc.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 F1 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $3.125 to $3.14 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 27, 2022 Filed Jan 28, 2022 19:51 UTC | LifeMD, Inc. LFMD · Entity 6521 | Exercise / conversionRestricted Stock Unit · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001362118-22-000006 · primary_doc.xml · derivative · entry 3 Yecies Eric Harold · CIK 0001834563 · General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert in common stock on a one-for-one basis. F1 · derivative.exercise_date: 12,500 RSUs vested on January 27, 2022. Of the remaining RSUs, 12,500 vest on January 27, 2023 and 12,500 RSUs vest on January 27, 2024. F1 · derivative.expiration_date: 12,500 RSUs vested on January 27, 2022. Of the remaining RSUs, 12,500 vest on January 27, 2023 and 12,500 RSUs vest on January 27, 2024. Read SEC document |
| January 27, 2022 Filed Jan 28, 2022 19:51 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantRestricted Stock Unit · Derivative | 37,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001362118-22-000006 · primary_doc.xml · derivative · entry 2 Yecies Eric Harold · CIK 0001834563 · General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires not disclosed F1 · derivative.exercise_date: 12,500 RSUs vested on January 27, 2022. Of the remaining RSUs, 12,500 vest on January 27, 2023 and 12,500 RSUs vest on January 27, 2024. F1 · derivative.expiration_date: 12,500 RSUs vested on January 27, 2022. Of the remaining RSUs, 12,500 vest on January 27, 2023 and 12,500 RSUs vest on January 27, 2024. Read SEC document |
| January 27, 2022 Filed Jan 28, 2022 19:51 UTC | LifeMD, Inc. LFMD · Entity 6521 | Exercise / conversionCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001362118-22-000006 · primary_doc.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2021 Filed Nov 23, 2021 16:58 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock, par value $0.01 | 7,400 | $4.12 | $30,488.00 |
DisclosureSEC source: 0001362118-21-000045 · primary_doc.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · CCO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,500 Read SEC document |
| May 19, 2021 Filed May 19, 2021 19:41 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 11,100 | $9.24 | $102,564.00 |
DisclosureSEC source: 0001362118-21-000011 · primary_doc.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · CCO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,100 F1 · price: The price reported represents the weighted average price of shares purchased. The shares were purchased at varying prices in the range of $9.18 - $9.30. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each price. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 00:16 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock, par value $0.001 | 1,500 | $20.29 | $30,435.00 |
DisclosureSEC source: 0001493152-21-004851 · ownership.xml · nonDerivative · entry 2 Yecies Eric Harold · CIK 0001834563 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 00:16 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock, par value $0.001 | 3,500 | $19.99 | $69,965.00 |
DisclosureSEC source: 0001493152-21-004851 · ownership.xml · nonDerivative · entry 1 Yecies Eric Harold · CIK 0001834563 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.